As of 2026-03-14, the Relative Valuation of Novocure Ltd (NVCR) is (85.07) USD. This relative valuation is based on P/E multiples. With the latest stock price at 12.01 USD, the upside of Novocure Ltd based on Relative Valuation is -808.4%.
The range of the Relative Valuation is (74.44) - (88.14) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 46.9x - 65.5x | 61.5x |
| Forward P/E multiples | 32.7x - 55.6x | 45.8x |
| Fair Price | (74.44) - (88.14) | (85.07) |
| Upside | -719.8% - -833.9% | -808.4% |
| Date | P/E |
| 2026-03-12 | -7.57 |
| 2026-03-11 | -7.95 |
| 2026-03-10 | -8.04 |
| 2026-03-09 | -8.14 |
| 2026-03-06 | -8.22 |
| 2026-03-05 | -8.97 |
| 2026-03-04 | -8.46 |
| 2026-03-03 | -8.38 |
| 2026-03-02 | -8.52 |
| 2026-02-27 | -8.62 |
| 2026-02-26 | -8.67 |
| 2026-02-25 | -9.45 |
| 2026-02-24 | -7.40 |
| 2026-02-23 | -6.92 |
| 2026-02-20 | -7.16 |
| 2026-02-19 | -7.18 |
| 2026-02-18 | -7.19 |
| 2026-02-17 | -7.02 |
| 2026-02-13 | -6.93 |
| 2026-02-12 | -7.90 |
| 2026-02-11 | -6.62 |
| 2026-02-10 | -6.60 |
| 2026-02-09 | -6.32 |
| 2026-02-06 | -6.39 |
| 2026-02-05 | -6.36 |
| 2026-02-04 | -7.29 |
| 2026-02-03 | -7.46 |
| 2026-02-02 | -7.68 |
| 2026-01-30 | -7.82 |
| 2026-01-29 | -7.80 |
| 2026-01-28 | -7.93 |
| 2026-01-27 | -8.23 |
| 2026-01-26 | -8.36 |
| 2026-01-23 | -8.48 |
| 2026-01-22 | -8.94 |
| 2026-01-21 | -8.55 |
| 2026-01-20 | -8.20 |
| 2026-01-16 | -8.60 |
| 2026-01-15 | -8.70 |
| 2026-01-14 | -8.68 |
| 2026-01-13 | -8.60 |
| 2026-01-12 | -8.94 |
| 2026-01-09 | -9.05 |
| 2026-01-08 | -9.37 |
| 2026-01-07 | -9.08 |
| 2026-01-06 | -9.01 |
| 2026-01-05 | -8.68 |
| 2026-01-02 | -8.27 |
| 2025-12-31 | -8.15 |
| 2025-12-30 | -8.33 |